Live Breaking News & Updates on Acetylsalicylic Acid

Stay updated with breaking news from Acetylsalicylic acid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Could Aspirin Help Treat Breast Cancer?

A new study found that taking aspirin as adjuvant therapy does not improve outcomes for patients with high-risk nonmetastatic breast cancer. ....

United States , Dana Farber Cancer Institute , Wendyy Chen , Jeannes Mandelblatt , Trial Impact Future Research , Drug Administration , Georgetown Lombardi Institute For Cancer , Data Support Aspirin , Treating Breast , Key Findings From , Georgetown Lombardi Institute , Aging Research , Findings From , Impact Future , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Alignant Neoplasia , Alignant Neoplasm , Acetylsalicylic Acid , Mammary Gland , Cancer Risk , Social Determinants Of Health , Social Determinants Of Health Sdoh , Adjuvant Therapy , Health Care Equity ,

What Happened to Aspirin? And What Replaces It?

Although low-dose aspirin to reduce the risk for first-time heart attacks and strokes was the standard of care for 30 years, the risk-benefit calculation has changed. ....

United States , Muhammad Maqsood , John Wong , American Heart Association , American College Of Cardiology , Us Preventive Services Task Force , Tufts University School Of Medicine , Vascular Center At Methodist Hospital , New England Journal , Services Task Force , Tufts University School , Debakey Heart , Vascular Center , Methodist Hospital , American College , Heart Failure , Cardiometabolic Risk , Cardiometabolic Risk Factors , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease ,

Ticagrelor Alone Cuts Bleeding Without More Events Post-PCI

Ticagrelor monotherapy safely cut bleeding by more than half after intervention for acute coronary syndrome, without an increase in MACCE, in the ULTIMATE-DAPT trial. ....

United Kingdom , New York , United States , Gloriam Steiner Gager , Shao Liang Chen , Jolantam Siller Matula , Wayne Batchelor , Icahn School Of Medicine , Vascular Institute , Academic Research Consortium , University Of Vienna , Mount Sinai Health System , Duke University , American College Of Cardiology Scientific Session , International Society On Thrombosis , New York City , Icahn School , American College , Cardiology Scientific Session , Nanjing Medical University , Nanjing First Hospital , Bleeding Academic Research Consortium , Occluded Arteries , International Society , Inova Heart , Medical University ,

How do acetylsalicylic acid and warfarin interact with various nutrients?

45 drug-nutrient interactions (DNIs) that modify micro-nutritional status, particularly focusing on how acetylsalicylic acid (ASA) and warfarin may affect patients through various mechanisms. ....

United States , Alekssafronov Shutterstock , American Institute Of Medicine , Potential Drug , Nutrient Interactions , Trace Elements , Associated Dietary Compounds , Acetylsalicylic Acid , Image Credit , American Institute , Vitamin C ,

Apixaban for Cryptogenic Stroke With Atrial Cardiopathy

In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not reduce recurrent stroke vs aspirin in the ARCADIA trial. ....

San Francisco , United States , New York , Gregorym Marcus , Bruce Ovbiagele , Hooman Kamel , University Of California , Weill Cornell Medicine , New York City , Stroke Cerebrovascular Accident Cva , Acetylsalicylic Acid , Intracranial Hemorrhage , Ntracranial Bleeding Intracranial Haemorrhage , Recurrent Stroke , Atrial Fibrillation Af , A Fib , Atrial Fib , Trial Fibrillation Af , Trial Fibrillationa Fib , F Atrial Fibrillation ,